{"transactions":[{"id":689279,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-12T20:37:56.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":6381734,"ownership":{"direct":false,"nature":"By Limited Liability Companies"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock).  Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock).  Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."}],"balance_after":6381734,"source":{"system":"sec-edgar","filing":"0001628280-26-056285","document":"wk-form4_1786567073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056285/wk-form4_1786567073.xml","form_type":"4"}},{"id":826395,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-27T20:19:46.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":544663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":544663,"derivative":{"underlying":"Class A Common Stock","underlying_shares":544663},"source":{"system":"sec-edgar","filing":"0001628280-26-021742","document":"wk-form4a_1774642784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026021742/wk-form4a_1774642784.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":858627,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":92593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":185185,"derivative":{"underlying":"Class A Common Stock","underlying_shares":92593},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858626,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":733944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":733944},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858625,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":59931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":179795,"derivative":{"underlying":"Class A Common Stock","underlying_shares":59931},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858624,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":37825,"price":13.3,"value":503072.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":1393470,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858623,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":92593,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1431295,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858622,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":297537,"price":13.31,"value":3960217.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":1338702,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858621,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":733944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":1636239,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858620,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":15616,"price":13.31,"value":207848.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":902295,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858619,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":59931,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":917911,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":867539,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-03T21:29:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":354031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 354,031 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 354,031 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":354031,"derivative":{"underlying":"Class A Common Stock","underlying_shares":354031},"source":{"system":"sec-edgar","filing":"0001628280-26-013893","document":"wk-form4_1772573340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013893/wk-form4_1772573340.xml","form_type":"4"}},{"id":867538,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T21:29:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":190632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."}],"balance_after":190632,"derivative":{"underlying":"Class A Common Stock","underlying_shares":190632},"source":{"system":"sec-edgar","filing":"0001628280-26-013893","document":"wk-form4_1772573340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013893/wk-form4_1772573340.xml","form_type":"4"}},{"id":1222578,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":92592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":277778,"derivative":{"underlying":"Class A Common Stock","underlying_shares":92592},"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222577,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":239726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."}],"balance_after":239726,"derivative":{"underlying":"Class A Common Stock","underlying_shares":239726},"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222576,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":890410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 445,205 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 445,205 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period."}],"balance_after":890410,"derivative":{"underlying":"Class A Common Stock","underlying_shares":890410},"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222575,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":579710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 2."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 2."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 2."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":579710},"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222574,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":47361,"price":8.84,"value":418671.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":857980,"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222573,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":92592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":905341,"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222572,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":279527,"price":8.76,"value":2448656.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":812749,"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1222571,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:33:40.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":579710,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 2."}],"balance_after":1092276,"source":{"system":"sec-edgar","filing":"0001628280-25-010693","document":"wk-form4_1741221213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010693/wk-form4_1741221213.xml","form_type":"4"}},{"id":1591771,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-03-06T22:39:19.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":1333334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 666,667 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 666,667 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."}],"balance_after":1333334,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1333334},"source":{"system":"sec-edgar","filing":"0001628280-24-009480","document":"wk-form4_1709764748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024009480/wk-form4_1709764748.xml","form_type":"4"}},{"id":1591770,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T22:39:19.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":370370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 4, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 4, 2025."}],"balance_after":370370,"derivative":{"underlying":"Class A Common Stock","underlying_shares":370370},"source":{"system":"sec-edgar","filing":"0001628280-24-009480","document":"wk-form4_1709764748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024009480/wk-form4_1709764748.xml","form_type":"4"}},{"id":1746809,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class B Common Stock and Common Units","published_at":"2023-11-08T23:20:55.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":false,"shares":21269420,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Issuer of the Common Units is Amneal Pharmaceuticals, LLC."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":21269420},"source":{"system":"sec-edgar","filing":"0001209191-23-054739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054739/doc4.xml","form_type":"4"}},{"id":1746808,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2023-11-08T23:20:55.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":true,"shares":21269420,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the \"Issuer\") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) (\"Old PubCo\") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC (\"AP\"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."}],"balance_after":21269420,"source":{"system":"sec-edgar","filing":"0001209191-23-054739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054739/doc4.xml","form_type":"4"}},{"id":1966085,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-03-07T23:00:40.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":733944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."}],"balance_after":733944,"derivative":{"underlying":"Class A Common Stock","underlying_shares":733944},"source":{"system":"sec-edgar","filing":"0001209191-23-016930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016930/doc4.xml","form_type":"4"}},{"id":2354822,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-03-04T02:20:17.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":1159420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a performance-based restricted stock unit grant of 579,710 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 579,710 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 579,710 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents a performance-based restricted stock unit grant of 579,710 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents a performance-based restricted stock unit grant of 579,710 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."}],"balance_after":1159420,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1159420},"source":{"system":"sec-edgar","filing":"0001209191-22-016054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016054/doc4.xml","form_type":"4"}},{"id":2466370,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2021-12-17T21:15:26.000Z","date":"2021-12-16","kind":"purchase","acquired":true,"shares":50000,"price":4.25,"value":212500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.30. The reporting person undertakes to provide the Company, any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":512566,"source":{"system":"sec-edgar","filing":"0001209191-21-070259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121070259/doc4.xml","form_type":"4"}},{"id":2466369,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2021-12-17T21:15:26.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":100000,"price":4.13,"value":413000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.06 to $4.18. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":462566,"source":{"system":"sec-edgar","filing":"0001209191-21-070259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121070259/doc4.xml","form_type":"4"}},{"id":2814141,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-03-03T22:08:12.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":926640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."}],"balance_after":926640,"derivative":{"underlying":"Class A Common Stock","underlying_shares":926640},"source":{"system":"sec-edgar","filing":"0001209191-21-017008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121017008/doc4.xml","form_type":"4"}},{"id":3156573,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Restricted Stock Units","published_at":"2020-05-08T23:11:18.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000899243-20-012451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/doc4.xml","form_type":"4"}},{"id":3156572,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Class A Common Stock","published_at":"2020-05-08T23:11:18.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":6459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":362566,"source":{"system":"sec-edgar","filing":"0000899243-20-012451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/doc4.xml","form_type":"4"}},{"id":3215972,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Class A Common Stock","published_at":"2020-03-11T23:54:09.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":100000,"price":3.09,"value":309000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.90 to $3.20, inclusive."}],"balance_after":356107,"source":{"system":"sec-edgar","filing":"0000899243-20-007988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/doc4.xml","form_type":"4"}},{"id":3217975,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Class A Common Stock","published_at":"2020-03-11T01:15:08.000Z","date":"2020-03-04","kind":"purchase","acquired":true,"shares":58938,"price":3.97,"value":233983.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.87 to $4.00, inclusive."}],"balance_after":256107,"source":{"system":"sec-edgar","filing":"0000899243-20-007821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/doc4.xml","form_type":"4"}},{"id":3217974,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Class A Common Stock","published_at":"2020-03-11T01:15:08.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":156421,"price":3.88,"value":606913.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.75 to $4.00, inclusive."}],"balance_after":197169,"source":{"system":"sec-edgar","filing":"0000899243-20-007821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/doc4.xml","form_type":"4"}},{"id":3217973,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Class A Common Stock","published_at":"2020-03-11T01:15:08.000Z","date":"2020-03-02","kind":"purchase","acquired":true,"shares":34641,"price":3.87,"value":134060.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.805 to $3.92, inclusive."}],"balance_after":40748,"source":{"system":"sec-edgar","filing":"0000899243-20-007821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/doc4.xml","form_type":"4"}},{"id":3238393,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, Co-CEO & Director"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2020-03-03T01:16:14.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":1266490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period."}],"balance_after":1266490,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1266490},"source":{"system":"sec-edgar","filing":"0000899243-20-006633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006633/doc4.xml","form_type":"4"}},{"id":3535241,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:45:33.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001723128-19-000065","document":"wf-form4_155735191794713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/wf-form4_155735191794713.xml","form_type":"4"}},{"id":3535240,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:45:33.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."}],"balance_after":6459,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0001723128-19-000065","document":"wf-form4_155735191794713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/wf-form4_155735191794713.xml","form_type":"4"}},{"id":3535239,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T21:45:33.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28044,"derivative":{"exercise_price":14.05,"expiration_date":"2029-05-06","underlying":"Class A Common Stock","underlying_shares":28044},"source":{"system":"sec-edgar","filing":"0001723128-19-000065","document":"wf-form4_155735191794713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/wf-form4_155735191794713.xml","form_type":"4"}},{"id":3535238,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-08T21:45:33.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":6107,"source":{"system":"sec-edgar","filing":"0001723128-19-000065","document":"wf-form4_155735191794713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/wf-form4_155735191794713.xml","form_type":"4"}},{"id":3871197,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Units","published_at":"2018-07-09T21:12:34.000Z","date":"2018-07-05","kind":"other","acquired":true,"shares":21269420,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."}],"balance_after":21269420,"derivative":{"underlying":"Common Units","underlying_shares":21269420},"source":{"system":"sec-edgar","filing":"0000899243-18-019661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318019661/doc4.xml","form_type":"4"}},{"id":3871196,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2018-07-09T21:12:34.000Z","date":"2018-07-05","kind":"other","acquired":true,"shares":21269420,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration."}],"balance_after":21269420,"source":{"system":"sec-edgar","filing":"0000899243-18-019661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318019661/doc4.xml","form_type":"4"}},{"id":3941186,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-09T22:36:29.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":6107,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0000899243-18-012158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012158/doc4.xml","form_type":"4"}},{"id":3941185,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-09T22:36:29.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":24977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":24977,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":24977},"source":{"system":"sec-edgar","filing":"0000899243-18-012158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012158/doc4.xml","form_type":"4"}}]}